Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....

BIOGEN PHARMACHEM INDUSTRIES LIMITED CIN NO: L51100GJ1995PLC026702 (Formerly Known as SUN TECHNO OVERSEAS LIMITED) Date: 21.07.2026 Department of Corporate Services BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Ref: Scrip Code: 531752 Scrip ID: BIOGEN Dear Sir / Madam, Sub: Compliance of Regulation 29 of SEBI (LODR) Regulations, 2015 - Intimation of Board meeting. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 5th August 2026 inter alia, to consider following businesses: - 1 To approve and take on record the Un-Audited Financial Results of the Company for the first quarter ended on 30th June 2026. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Yours Faithfully, FOR, BIOGEN PHARMACHEM INDUSTRIES LIMITED Kelash Bunkar Director Registered Office Address: Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001 E mail biogenpharmachem@gmail.com